Using big data to target gene mutations in cancer tumor cells Jan. 18, 2024 Researchers are leveraging molecular profiling data to better understand certain cancers and uncover new treatments. Read more Image
Severe weather across country puts pressure on Southern Arizona blood banks Jan. 17, 2024 The University of Arizona College of Medicine – Tucson is doing its part to help alleviate what the American Red Cross is calling a nationwide blood shortage. KOLD-TV (Tucson, AZ)
Fitness as your body fluctuates Jan. 17, 2024 Injuries, sickness and aging should cause adaptations to your workout routine. NPR Life Kit Podcast
Hobbs' $16 billion budget plan depends on cutting school vouchers Jan. 16, 2024 During her annual State of the State address, Arizona Gov. Katie Hobbs mentioned doubling the size of the College of Medicine – Phoenix and College of Medicine – Tucson as part of a larger effort to expand access to health care statewide. Arizona Daily Star
Opvee nasal spray: a newer approach to help opioid overdoses Jan. 16, 2024 Opvee®, a recently approved nasal spray for opioid overdose reversal, offers a faster and longer-lasting alternative to Narcan®, but experts warn its focus on synthetic opioids such as fentanyl and outdated data could mask potential drawbacks. KGUN-TV (Tucson, AZ)
What happens when we sleep and why we need just the right amount each night Jan. 16, 2024 A growing body of research shows getting little or poor sleep doesn’t just make people feel tired the next day – it places them at higher risk for heart attacks and early death, along with cognitive decline, dementia, diabetes, high blood pressure, obesity, depression and other chronic health conditions. Sleep Review
Fostering career everywhere: Innovative approaches to career readiness Jan. 16, 2024 Spencer Willis Jr., DrPH, associate professor of practice at the Mel and Enid Zuckerman College of Public Health, co-authors an article about helping educators from diverse institutions boost career readiness by presenting various strategies that suit different comfort levels and degrees of engagement. Faculty Focus
FDA approves pembrolizumab plus chemoradiotherapy to treat FIGO 2014 stage III-IVA cervical cancer Jan. 16, 2024 The Food and Drug Administration has approved pembrolizumab, an anti-programmed death receptor-1 therapy, plus chemoradiotherapy, to treat individuals with International Federation of Gynecology and Obstetrics 2014 stage III-IVA cervical cancer. Pharmacy Times
Connecting with Dean Hyochol Brian Ahn Jan. 16, 2024 New Nursing dean says technology, including AI, will enhance research and education to reach even more of those in need of care. Read more Image